This study aimed to evaluate real-world clinical outcome of patients needing short dual antiplatelet therapy (S-DAPT) following PCI with Ultimaster® thin-strut, biodegradable polymer sirolimus-eluting stent (BP-SES), which was supposed to induce faster stent endothelialization and reduce device thrombogenicity.

One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients needing short dual antiplatelet therapy. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)

Ferrante, Giuseppe;Chiarito, Mauro;Colombo, Antonio
2019

Abstract

This study aimed to evaluate real-world clinical outcome of patients needing short dual antiplatelet therapy (S-DAPT) following PCI with Ultimaster® thin-strut, biodegradable polymer sirolimus-eluting stent (BP-SES), which was supposed to induce faster stent endothelialization and reduce device thrombogenicity.
Biodegradable polymer sirolimus-eluting stent
Dual antiplatelet therapy
High bleeding risk
Percutaneous coronary intervention
Stent thrombosis
Absorbable Implants
Acute Coronary Syndrome
Aged
Aged, 80 and over
Drug-Eluting Stents
Follow-Up Studies
Humans
Immunosuppressive Agents
Italy
Middle Aged
Platelet Aggregation Inhibitors
Polymers
Retrospective Studies
Sirolimus
Time Factors
Treatment Outcome
Registries
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/69701
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact